BLFS Q4 2023 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q4 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$17M-60.7% YoY

Gross Profit

$9M52.1% margin

Operating Income

-$7M-42.9% margin

Net Income

-$13M-77.0% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

-26.2%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$1M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$413M

Total Liabilities

$75M

Stockholders' Equity

$338M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$44M	-60.7%
Gross Profit	$9M	$14M	-35.2%
Operating Income	-$7M	-$10M	+27.0%
Net Income	-$13M	-$49M	+72.8%

Revenue Segments

Product

$58M84%

Service

$9M13%

Rental Revenue

$2M3%